Decongestant products have emerged over the past year as a growing, but seperate, single remedy sector.
GSK OTC category manager Greg Bertolotti attributes the emergence of this sector to two factors: first, that in mild winters, there are congestion rather than fever-related conditions, and second, manufacturers have in general tended to favour high-fever product npd. The result has been that grocers' sales in this subsector have risen ahead of the market as a whole  13% by value and 17.8% by volume.
Reckitt Benckiser attributes grocery's performance to high-profile GSL launches such as Sudafed Dual Relief, which RB estimates brought 900,000 new consumers into the market. New to the GSL fixture this year are Lemsip Max Strength Sinus Relief capsules, which contain the maximum amounts of active ingredient available on general sale, and Beechams Decongestant Plus with paracetamol, while on the P fixture there is the new Sudafed 12-Hour Relief.
{{FOCUS ON }}
GSK OTC category manager Greg Bertolotti attributes the emergence of this sector to two factors: first, that in mild winters, there are congestion rather than fever-related conditions, and second, manufacturers have in general tended to favour high-fever product npd. The result has been that grocers' sales in this subsector have risen ahead of the market as a whole  13% by value and 17.8% by volume.
Reckitt Benckiser attributes grocery's performance to high-profile GSL launches such as Sudafed Dual Relief, which RB estimates brought 900,000 new consumers into the market. New to the GSL fixture this year are Lemsip Max Strength Sinus Relief capsules, which contain the maximum amounts of active ingredient available on general sale, and Beechams Decongestant Plus with paracetamol, while on the P fixture there is the new Sudafed 12-Hour Relief.
{{FOCUS ON }}
No comments yet